Information Provided By:
Fly News Breaks for November 14, 2016
ESPR
Nov 14, 2016 | 08:02 EDT
Citi analyst Joel Beatty downgraded Esperion Therapeutics to Neutral saying he does not expect significant stock moves over the next 12 months with Phase III data for Bempedoic Acid not coming until mid-2018.
News For ESPR From the Last 2 Days
ESPR
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here